Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(S)-AMPA is the active enantiomer of AMPA, a synthetic non-proteinogenic alpha-amino acid and potent, selective agonist for the AMPA subtype of ionotropic glutamate receptors. It mimics the action of glutamate at these receptors, inducing fast excitatory postsynaptic potentials by activating non-selective cation channels permeable to sodium and potassium ions. This compound is widely used as an experimental tool in neuroscience research to study synaptic transmission and receptor pharmacology. The R-enantiomer is virtually inactive at these sites. Its primary use is in laboratory research; it has no approved therapeutic indications[1][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (S)-AMPA.